20 hrs ago
Why releasing untested ebola drugs was the right thing to do
Nurses wearing protective suits escort a man infected with the ebola virus to a hospital in Monrovia, Liberia, 25 August.
21 hrs ago
Cancer 101 Pictures Slideshow: A Visual Guide to Understanding Cancer
In the most basic terms, cancer refers to cells that grow out-of-control and invade other tissues.
The Otago Daily Times
Advance for Pacific Edge
The signing of an agreement with a Californian medical group is further confirmation Pacific Edge Ltd is ''moving forward'' in the United States, Craigs Investment Partners broker Peter McIntyre says.
Takeda Announces Completion of the Post-Marketing Commitment to...
In the five-year interim analysis published in Diabetes Care , a statistically significant increased risk among patients who used pioglitazone for two or more years was observed.1 However, the 10-year final analysis did not show any statistically significant findings of increased risk of bladder cancer with long term use of pioglitazone.2 The data ... (more)
What You Missed From Regulatory Agencies Recently - August 18-28, 2014
NICE has published final draft guidance stating that Celgene's Revlimid for myelodysplastic syndromes will be available on the NHS in England.
Women's bladder cancer scanner handed over
Burnley MP Gordon Birtwistle and his fund-raising team hand over the new i 1 210,000 scanner which can detect ladies bladder scanner to Mohan Pillai and Shahid Islam at the Urology Unit in Burnley General Hospital.
Wed Aug 27, 2014
Data from Mayo Clinic Provide New Insights into Bladder Cancer...
Metastasis to the central nervous system is uncommon occurring in The news correspondents obtained a quote from the research from , "When present, metastatic lesions are typically solid, isolated and located in the cerebrum.
Altor BioScience Awarded SBIR Phase II Grant by NCI for Clinical...
NCI ranks bladder cancer as the 6th most common cancer in the U.S., and approximately 70 percent of patients with bladder cancer have NMIBC at diagnosis, making it one of the most prevalent cancers in the U.S .
Tue Aug 26, 2014
Kaiser Permanente signs up for Cxbladder
Pacific Edge Ltd has signed an agreement with Southern California Permanente Medical Group to research its User Program to evaluate its bladder cancer technology Cxbladder within the clinical settings of Kaiser Permanente's health care network.
Cardinal George cancels trip to Rome so he can receive cancer treatment
Cardinal Francis George will miss a planned trip to Rome in October to instead receive treatment for cancer, the Archdiocese of Chicago said Tuesday.
New tool to probe cancer's molecular make-up
Scientists have shown how to better identify and measure vital molecules that control cell behaviour - paving the way for improved tools for diagnosis, prediction and monitoring of cancer.
Mon Aug 25, 2014
Cardinal George participating in clinical trial of anti-cancer drug
Chicago, Ill., Aug 25, 2014 / 10:46 am .- Cardinal Francis George of Chicago is continuing cancer treatment and has agreed to take part in a clinical trial of a new anti-cancer drug, his archdiocese has announced.
Applied Clinical Trials
Spring Bioscience launches highly sensitive PD-L1 (SP142) antibody, a ...
This new PD-L1 clone was developed for Roche/Genentech's anti-PD-L1 immunotherapy development program.
Fri Aug 22, 2014
Cardinal George testing new cancer drug
Cardinal Francis George, facing his third bout with cancer, is participating in a clinical trial of a new drug being conducted at the University of Chicago, the archdiocese announced Friday.
Thu Aug 21, 2014
Building Presence in World's Largest Biomedical Market
At its annual shareholders' meeting held yesterday in Dunedin, New Zealand, cancer diagnostic developer, Pacific Edge, celebrated the commercial launch of its flagship bladder cancer diagnostic product, Cxbladder, into the US and provided shareholders with an update on its growth plans.
Surgery associated with better survival for patients with advanced laryngeal cancer
Approximately 11,000 to 13,000 cases of laryngeal cancer are diagnosed each year and squamous cell carcinoma accounts for the vast majority of these tumors.
Arutz Sheva Israel News
Technology & HealthWoman's Cancer Drives Daughter to Research Breakthrough
Dr. Svetlana Bunimovich, lecturer in the Department of Computer Science and Mathematics at the University of Ariel, will present research done using mathematical models, to improve the treatment of bladder cancer, at a conference to be held at Ariel University next week .
Wed Aug 20, 2014
Validation of RiskCheck Bladder Cancera OEA , version 5.0 for...
The aim of the study was to assess the strength of the online tool RiskCheck Bladder CancerA©, version 5.0 for early detection of bladder cancer .
Largest cancer genomic study proposes 'disruptive' new system to reclassify tumors
TCGA scientists analyzed the DNA, RNA and protein from 12 different tumor types using six different TCGA "platform technologies" to see how the different tumor types compare to each other.
Tue Aug 19, 2014
Revealed: The most devastating failures by public services
Paul Gallagher is a reporter for the Independent and Independent on Sunday having joined the group in 2012.